Lasix and Nyquil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lasix (furosemide) and Nyquil (acetaminophen / dextromethorphan / doxylamine / pseudoephedrine). Common drug interactions include anaemia among females and nail hypertrophy among males.

The phase IV clinical study analyzes what interactions people have when they take Lasix and Nyquil. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Lasix?

Lasix has active ingredients of furosemide. It is often used in swelling. eHealthMe is studying from 210,439 Lasix users. Check the latest studies of Lasix.

What is Nyquil?

Nyquil has active ingredients of acetaminophen / dextromethorphan / doxylamine / pseudoephedrine. It is often used in cold symptoms. eHealthMe is studying from 2,240 Nyquil users. Check the latest studies of Nyquil.



On Jul, 26, 2026

30 people who take Lasix and Nyquil together, and have interactions are studied.

Lasix and Nyquil drug interactions.

What are the common drug interactions of Lasix and Nyquil, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Abdominal discomfort
  3. Abdominal pain upper
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Constipation
  6. Diarrhoea
  7. Headache (pain in head)
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Nausea (feeling of having an urge to vomit)
  10. Pain in extremity

male:

  1. Nail hypertrophy (overgrowth or thickening of the nail)
  2. Post procedural haemorrhage (post procedural bleeding)
  3. Urinary tract infection
  4. Acidosis (build-up of carbon dioxide in the blood)
  5. Acute hepatic failure
  6. Anaemia (lack of blood)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Cardiac tamponade (fluid accumulates in heart covering)
  9. Cardiogenic shock (inadequate circulation of blood)
  10. Confusional state

What are the common drug interactions of Lasix and Nyquil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal failure (kidney dysfunction)

30-39:

  1. Chest pain
  2. Dyspnoea (difficult or laboured respiration)

40-49:

  1. Abdominal pain
  2. Anxiety
  3. Cholecystitis chronic (long lasting infection of gallbladder)
  4. Emotional distress
  5. General physical health deterioration (weak health status)
  6. Injury
  7. Pain
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Subclavian vein thrombosis (abnormal condition in which a clot develops within the subclavian or axillary vein)
  10. Thrombosis (formation of a blood clot inside a blood vessel)

50-59:

  1. Hepatic failure (liver failure)
  2. Death
  3. Drug abuse
  4. Hydronephrosis (water inside the kidney)
  5. Multi-organ failure (multisystem organ failure)
  6. Overdose
  7. Renal failure (kidney dysfunction)
  8. Abdominal compartment syndrome (increased pressure in abdomen)
  9. Acidosis (build-up of carbon dioxide in the blood)
  10. Acute hepatic failure

60+:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Urinary tract infection
  3. Nail hypertrophy (overgrowth or thickening of the nail)
  4. Post procedural haemorrhage (post procedural bleeding)
  5. Prostatic disorder
  6. Pruritus (severe itching of the skin)
  7. Anaemia (lack of blood)
  8. Cardiac tamponade (fluid accumulates in heart covering)
  9. Confusional state
  10. Death

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 7 people, 23.33%
  2. Pain: 6 people, 20.00%
  3. High Blood Pressure: 4 people, 13.33%
  4. Immunodeficiency: 4 people, 13.33%
  5. Cough: 3 people, 10.00%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 10.00%
  7. Joint Pain: 3 people, 10.00%
  8. Hypergammaglobulinaemia (elevated levels of gamma globulin): 3 people, 10.00%
  9. High Blood Cholesterol: 3 people, 10.00%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lasix and Nyquil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lasix and Nyquil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lasix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nyquil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lasix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nyquil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on furosemide and acetaminophen / dextromethorphan / doxylamine / pseudoephedrine (the active ingredients of Lasix and Nyquil, respectively), and Lasix and Nyquil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: